Cboe CA - Delayed Quote CAD
Cybin Inc. (CYBN.NE)
At close: October 18 at 3:59 PM EDT
Research Analysis
Earnings Per Share
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 3 | 3 |
| Avg. Estimate | -1.01 | -1.01 | -3.67 | -4.94 |
| Low Estimate | -1.14 | -1.14 | -4.18 | -6.08 |
| High Estimate | -0.76 | -0.76 | -3.04 | -3.8 |
| Year Ago EPS | -1.9 | -3.42 | -9.5 | -3.67 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 3 | 3 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | -- | -- | -- |
Earnings History
| CURRENCY IN USD | 9/30/2023 | 12/31/2023 | 3/31/2024 | 6/30/2024 |
|---|---|---|---|---|
| EPS Est. | -1.9 | -1.52 | -1.61 | -1.33 |
| EPS Actual | -1.9 | -3.42 | -0.76 | -0.76 |
| Difference | 0 | -1.9 | 0.85 | 0.57 |
| Surprise % | 0.00% | -125.00% | 52.80% | 42.90% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -1.01 | -1.01 | -3.67 | -4.94 |
| 7 Days Ago | -0.03 | -0.03 | -0.1 | -0.13 |
| 30 Days Ago | -0.04 | -0.04 | -0.15 | -0.2 |
| 60 Days Ago | -0.02 | -0.03 | -0.09 | -0.11 |
| 90 Days Ago | -0.02 | -0.02 | -0.15 | -0.1 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | 1 | 1 | 2 | 2 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | CYBN.NE | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 46.80% | -- | -- | 3.80% |
| Next Qtr. | 70.50% | -- | -- | 8.00% |
| Current Year | 61.40% | -- | -- | 2.50% |
| Next Year | -34.60% | -- | -- | 13.10% |
| Next 5 Years (per annum) | -- | -- | -- | 11.88% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Upgrades & Downgrades
| Maintains | Canaccord Genuity: Buy to Buy | 9/23/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 8/23/2024 |
| Reiterates | Cantor Fitzgerald: Overweight | 7/31/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 7/31/2024 |
| Reiterates | Cantor Fitzgerald: Overweight | 6/21/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 5/16/2024 |
Related Tickers
PHRM.CN PharmaTher Holdings Ltd.
0.2900
+23.40%
MDMA.CN Pharmala Biotech Holdings Inc.
0.1450
+3.57%
ATAI Atai Life Sciences N.V.
1.2800
+6.67%
MNMD Mind Medicine (MindMed) Inc.
6.61
+2.96%
DRUG.CN Bright Minds Biosciences Inc.
102.72
+242.40%
ENBI.CN Entheon Biomedical Corp.
0.1400
-6.67%
AWKN.CN AwaknLifeSc
0.1250
+25.00%
MDXXF Pharmala Biotech Holdings Inc.
0.1060
0.00%
MDNA.TO Medicenna Therapeutics Corp.
2.2800
-3.39%
PHRRF PharmaTher Holdings Ltd.
0.2080
+4.00%